Cargando…
Deep-learning algorithm to detect fibrosing interstitial lung disease on chest radiographs
BACKGROUND: Antifibrotic therapies are available to treat chronic fibrosing interstitial lung diseases (CF-ILDs), including idiopathic pulmonary fibrosis. Early use of these treatments is recommended to slow deterioration of respiratory function and to prevent acute exacerbation. However, identifyin...
Autores principales: | Nishikiori, Hirotaka, Kuronuma, Koji, Hirota, Kenichi, Yama, Naoya, Suzuki, Tomohiro, Onodera, Maki, Onodera, Koichi, Ikeda, Kimiyuki, Mori, Yuki, Asai, Yuichiro, Takagi, Yuzo, Honda, Seiwa, Ohnishi, Hirofumi, Hatakenaka, Masamitsu, Takahashi, Hiroki, Chiba, Hirofumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932351/ https://www.ncbi.nlm.nih.gov/pubmed/36202411 http://dx.doi.org/10.1183/13993003.02269-2021 |
Ejemplares similares
-
Pneumocystis jirovecii Pneumonia Associated with COVID-19 in Patients with Interstitial Pneumonia
por: Takahashi, Tomoyuki, et al.
Publicado: (2022) -
Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage
por: Shioya, Makoto, et al.
Publicado: (2018) -
Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
por: Yoshikawa, Takumi, et al.
Publicado: (2020) -
Correction to: Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
por: Yoshikawa, Takumi, et al.
Publicado: (2020) -
Distinct compartmentalization of SP-A and SP-D in the vasculature and lungs of patients with idiopathic pulmonary fibrosis
por: Nishikiori, Hirotaka, et al.
Publicado: (2014)